Oral Liken Planus Hastalarında Tükürük Kortizol Seviyesi, Kaygı Durumu ve Periodontal Enflamasyonun Değerlendirilmesi

Öz

Amaç: Çalışmanın amacı sağlıklı bireyler ve oral liken planus (OLP) hastalarında kaygı düzeylerinin ve tükürük kortizol seviyelerinin değerlendirilmesidir. Hastaların periodontal sağlıklarının belirlenerek karşılaştırılması da hedeflenmektedir. Yöntem: Katılımcılar E.Ü. Diş Hekimliği Fakültesine muayene amacıyla başvuran bireyler arasından belirlendi. OLP hasta grubu, ağızda OLP’ye bağlı yakınmaları olan ve OLP tanısı histopatolojik olan doğrulanmış hastalardan oluşturulurken, kontrol grubu rutin muayene amacıyla başvurmuş bireyler arasından seçildi. Demografik veriler kaydedildi ve hastalardan durumluk-sürekli anksiyete (STAI-II) ölçeğinin ikinci bölümünü doldurmaları istendi. Tükürük örnekleme sonrasında, plak ve kanama indeksleri ölçülerek periodontal durum değerlendirildi. Tükürük kortizol konsantrasyonları ticari bir kit kullanılarak belirlendi. Veriler t-testi, Mann-Whitney U testi ve ki-kare ve Pearson korelasyonu ile değerlendirildi (p<0,05). Bulgular: Çalışmaya 54 OLP hastası ve 47 sağlıklı birey olmak üzere toplam 101 hasta dâhil edildi. Gruplar arasında yaş ve cinsiyet dağılımı benzerdi (p>0,05). Sondalamada kanama yüzdesi (p=0,368), plak yüzdesi (p=0,668) ve gingivitis varlığı (p=0,546) açısından anlamlı fark belirlenmedi. OLP grubun ortalama STAI-II değeri (47,54) kontrol grubuna oranla (42,60) anlamlı şekilde daha yüksekti (p=0,002). Ancak ortalama tükürük kortizol seviyelerinin sağlıklı grupta (3864,30 pg/ml) OLP grubuna kıyasla (3337,11 pg/ml) anlamlı şekilde daha yüksek olduğu belirlendi (p=0,005). Korelasyon analizleri, OLP grubunda yaş ve STAI-II skoru ile (p=0,020) sondalamada kanama yüzdesi (p=0,028) arasında pozitif bir ilişki varlığını gösterdi. Her iki grupta da STAI-II skoru ve tükürük kortizol seviyesi arasında anlamlı bir korelasyon gözlenmedi. Sonuç: OLP hastalarında psikolojik faktörlerin etkisi nöroendokrin etkenlerden daha baskın olabilir. Bu hastaların tedavisinde uygulanacak multidisipliner yaklaşıma psikolojik/psikiyatrik uzmanların da dahil edilmesi tedavi etkinliğinin ve hastanın yaşam kalitesinin artırılmasına önemli katkılar sağlayabilir.

Anahtar Kelimeler

• oral liken planus
• stres
• kaygı düzeyi
• STAI

Evaluation of Salivary Cortisol Levels, Anxiety Status, and Periodontal Inflammation in Patients with Oral Lichen Planus

Öz

Aim: This study aims to evaluate anxiety levels and salivary cortisol concentrations in both healthy individuals and patients with oral lichen planus (OLP), and to compare their periodontal health status. Methods: Participants were selected from those visiting the E.U. Faculty of Dentistry. The OLP group consisted of individuals with confirmed OLP through histopathological diagnosis, while the control group included individuals attending for routine dental check-ups. Demographic data were recorded, and participants completed the second part of the State-Trait Anxiety Inventory (STAI-II). Saliva samples were collected, and plaque and bleeding indices were assessed to gauge periodontal health. Salivary cortisol levels were measured using a commercial kit. Statistical analyses were performed using t-tests, Mann-Whitney U tests, chi-square tests, and Pearson correlation coefficients (p<0.05). Results: A total of 101 participants were included, with 54 in the OLP group and 47 controls. Age and gender distributions were similar between groups (p>0.05). The OLP group had significantly higher STAI-II scores (mean of 47.54) compared to the control group (mean of 42.60) (p=0.002). In contrast, salivary cortisol levels were significantly higher in the healthy group (mean of 3864.30 pg/ml) compared to the OLP group (mean of 3337.11 pg/ml) (p=0.005). Correlation analyses indicated a positive relationship between age, STAI-II scores, and bleeding on probing in the OLP group. Conclusion: Psychological factors may exert a greater influence than neuroendocrine factors in OLP patients. Integrating psychological and psychiatric specialists into a multidisciplinary treatment approach could significantly improve treatment outcomes and enhance the quality of life for these patients.

Anahtar Kelimeler

• oral lichen planus
• stress
• level of anxiety
• STAI

Kaynakça

1. 1. Gorouhi, F., Davari, P., Fazel, N. 2014. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Scientific World Journal, 2014, 742826.
2. 2. Parashar, P. 2011. Oral lichen planus. Otolaryngol Clin North Am, 44(1), 89-107.
3. 3. Eisen, D. 1999. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 88(4), 431-436.
4. 4. Warnakulasuriya, S., Kujan, O., Aguirre-Urizar, J. M., Bagan, J. V., González-Moles, M. Á., Kerr, A. R., Lodi, G., Mello, F. W., Monteiro, L., Ogden, G. R., Sloan, P., Johnson, N. W. 2021. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis, 27(8), 1862-1880.
5. 5. Georgakopoulou, E. A., Achtari, M. D., Achtaris, M., Foukas, P. G., Kotsinas, A. 2012. Oral lichen planus as a preneoplastic inflammatory model. Journal of Biomedicine & Biotechnology, 2012, 759626.
6. 6. Chainani-Wu, N., Silverman, S. J., Lozada-Nur, F., Mayer, P., Watson, J. 2001. Oral lichen planus: Patient profile, disease progression and treatment responses. Journal of the American Dental Association, 132(7), 901–909.
7. 7. Giuliani, M., Troiano, G., Cordaro, M., Corsalini, M., Gioco, G., Lo Muzio, L., Pignatelli, P., Lajolo, C. 2019. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis, 25(3), 693-709.
8. 8. Aghbari, S., Abushouk, A., Attia, A., Elmaraezy, A., Menshawy, A., Ahmed, M., Ahmed, E. 2017. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncology, 68, 92–102.

9. 9. Sawyers, C., Sheerin, C., Moore, A. A., Neigh, G., Hettema, J. M., Roberson-Nay, R. 2024. Genetic and environmental influences on alpha amylase stress reactivity and shared genetic covariation with cortisol. Psychoneuroendocrinology, 161, 106922.
10. 10. Chaitanya, N. C., Reshmapriyanka, D., Pallavi, K., Ameer, S., Appala, A., Chowdhary, A., Prabhath, T., Pota Ratna, M., Sai Sowmya, B., Vaishnavi, C., Bontala, P. 2020. Serological and psychological assessment of patients with oral lichen planus using serum cortisol levels and hads questionnaire—a case control study. Journal of Population Therapeutics and Clinical Pharmacology, 27(2), e19-e27.
11. 11. Kaur, B., Sunil, M. K., Trivedi, A., Singla, N., Garg, S., Goyal, N. 2015. Salivary Cortisol as a Diagnostic Marker in Oral Lichen Planus. J. Int. Oral Health, 7, 43–48.
12. 12. Nadendla, L. K., Meduri, V., Paramkusam, G., Pachava, K. R. 2014. Association of salivary cortisol and anxiety levels in lichen planus patients. J. Clin. Diagn. Res, 8, ZC01–ZC03. doi: 10.7860/JCDR/2014/8058.5225.
13. 13. Koray, M., Dülger, O., Ak, G., Horasanli, S., Uçok, A., Tanyeri, H., Badur, S. 2003. The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis, 9, 298–301.
14. 14. Nosratzehi, T., Arbabi-Kalati, F., Salimi, S., Honarmand, E. 2014. The Evaluation of Psychological Factor and Salivary Cortisol and IgA Levels in Patients with Oral Lichen Planus. Zahedan J. Res. Med. Sci, 16, 31–34.
15. 15. Taghavi Zenouz, A., Mehdipour, M., Dadashzadeh, H., Rafieyan, S. 2014. Evaluation of relationship between salivary cortisol levels and stress intensity in oral lichen planus patients. Der. Pharm. Lett, 6, 459–461.
16. 16. Miricescu, D., Totan, A., Calenic, B., Mocanu, B., Greabu, M. 2015. Salivary and serum cortisol in patients with periodontal disease and oral lichen planus. Stomatol. Edu J, 2, 51–56.
17. 17. Girardi, C., Luz, C., Cherubini, K., de Figueiredo, M. A., Nunes, M. L., Salum, F. G. 2011. Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. Arch. Oral Biol, 56, 864–868.
18. 18. Karthikeyan, P., Aswath, N. 2016. Stress as an etiologic co-factor in recurrent aphthous ulcers and oral lichen planus. J. Oral Sci, 58, 237–240.
19. 19. Vassandacoumara, V., Daniel, J. M. 2017. Correlation between salivary cortisol levels and Hospital Anxiety and Depression scores in oral lichen planus and recurrent aphthous stomatitis. Stomatol. Dis. Sci, 1, 103–108.
20. 20. Lopez-Jornet, P., Cayuela, C. A., Tvarijonaviciute, A., Parra-Perez, F., Escribano, D., Ceron, J. 2016. Oral lichen planus: Salival biomarkers cortisol, immunoglobulin A, adiponectin. J. Oral Pathol. Med, 45, 211–217.
21. 21. Lin, A., Mertens, A. N., Rahman, M. Z., et al. 2024. A cluster-randomized trial of water, sanitation, handwashing and nutritional interventions on stress and epigenetic programming. Nat Commun, 15(1), 3572.
22. 22. Robson, E., Norris, T., Hamer, M., Costa, S., Hardy, R., Johnson, W. 2021. The relationship of childhood adversity with diurnal cortisol patterns and C-reactive protein at 60-64 years of age in the 1946 National Survey of Health and Development. Psychoneuroendocrinology, 132, 105362.
23. 23. Pantell, M. S., Silveira, P. P., de Mendonça Filho, E. J., et al. 2024. Associations between Social Adversity and Biomarkers of Inflammation, Stress, and Aging in Children. Pediatr Res, 95(6), 1553-1563. doi:10.1038/s41390-023-02992-6.
24. 24. Hajishengallis, G., Chavakis, T. 2021. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol, 21, 426–440.
25. 25. Pekiner, F. N., Borahan, M. O., Özbayrak, S. 2014. Oral Liken Planus (OLP)’lu Bireylerde Kortizol, Anksiyete ve Depresyon Düzeylerinin Değerlendirilmesi. MÜSBED, 4(1), 24-28.
26. 26. Eisen, D., Carrozzo, M., Bagan Sebastian, J. V., Thongprasom, K. 2005. Number V Oral lichen planus: clinical features and management. Oral Dis, 11(6), 338-349.
27. 27. Rödström, P. O., Jontell, M., Hakeberg, M., Berggren, U., Lindstedt, G. 2001. “Erosive oral lichen planus and salivary cortisol”, J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol, 30(5), 257-263. doi: 10.1034/j.1600-0714.2001.300501.x.
28. 28. Vallejo, M. J., Huerta, G., Cerero, R., Seoane, J. M. 2001. “Anxiety and depression as risk factors for oral lichen planus”, Dermatol. Basel Switz, 203(4), 303-307.
29. 29. Hampf, B. G., Malmström, M. J., Aalberg, V. A., Hannula, J. A., Vikkula, J. 1987. “Psychiatric disturbance in patients with oral lichen planus”, Oral Surg. Oral Med. Oral Pathol, 63(4), 429-432.
30. 30. De Porras-Carrique, T., González-Moles, M. Á., Warnakulasuriya, S., Ramos-García, P. 2022. Depression, anxiety, and stress in oral lichen planus: a systematic review and meta-analysis. Clin Oral Investig, 26(2), 1391-1408.
31. 31. Lowental, U., Pisanti, S. 1984. Oral lichen planus according to the modern medical model. J Oral Med, 39, 2244.
32. 32. Delavarian, Z., Javadzadeh-Bolouri, A., Dalirsani, Z., Arshadi, H. R., Toofani-Asl, H. 2010. The evaluation of psychiatric drug therapy on oral lichen planus patients with psychiatric disorders. Med Oral Patol Oral Cir Bucal, 15, 322-327.
33. 33. Song, X., Wu, X., Wang, C., Sun, S., Zhang, X. 2021. Case Report: Treatment of oral lichen planus with a focus on psychological methods. Front Psychiatry, 12, 731093.
34. 34. Javaid, M. A., Ahmed, A. S., Durand, R., Tran, S. D. 2016. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res, 6(1), 66-75.
35. 35. Ivanovski, K., Nakova, M., Warburton, G., Pesevska, S., Filipovska, A., Nares, S., Nunn, M. E., Angelova, D., Angelov, N. 2005. Psychological profile in oral lichen planus. J Clin Periodontol, 32(10), 1034-1040.